Related Experiment Video
Updated: Dec 29, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Interest in Tobacco Treatment Delivered During Rideshare Travel
Jonathan Shuter1,2, Angie Yang3, Ryung S Kim1
1Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY.
Abstract:
More than 37,000,000 US adults smoke cigarettes. Most are interested in quitting, but rates of successful cessation remain low. Developing more and better approaches to tobacco treatment is a public health priority. The evolution of vehicular travel may present an opportunity for tobacco treatment intervention. We recruited individuals who reported previous use of ridesharing services (eg, Uber or Lyft) at 10 sites in the Boston area. They completed an anonymous survey that collected sociodemographic and tobacco use information and assessed participants' interest in receiving various forms of tobacco treatment during their rideshare rides. Forty-nine adult smokers completed the survey. Mean age = 40.1, 61.2% male, 51.0% white, 16.3% African American/black, 14.3% Latino, and 8.2% Asian. Almost 70% were college graduates, 79.6% worked full time, and 40.8% used ridesharing services ≥ weekly. They smoked a mean of 8.7 cigarettes per day; 35.3% were moderately or highly nicotine dependent, 36.7% also smoked cigars, 34.7% also used e-cigarettes, and 41.7% were in the contemplation or preparation stage of quitting. More than 56% of participants expressed some level of interest in receiving quit-smoking messaging during their rideshare rides. On multivariate analysis, black or Latino race/ethnicity and rideshare frequency of at least once a week were associated with interest in receiving quit-smoking messaging during rideshare rides. The majority of rideshare users who smoke are amenable to the idea of quit-smoking messaging delivered to them during their rides, and interest rates were highest among black or Latino riders and those who used rideshare services most frequently.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...